Latest Cystoscopy Stories

FLORIDA, Aug. 15, 2012 /PRNewswire-iReach/ -- Poiesis Medical has unveiled the first urinary catheter designed to address the risks associated with urinary catheterization. The traditional Foley catheters used today are clinically proven to cause trauma to the bladder; creating significant complications such as cystitis, hematuria, CAUTI (catheter associated urinary tract infections), and in long term catheter users, an increased risk of bladder cancer. The CDC estimates CAUTI alone...

OSLO, Norway, September 27, 2011 /PRNewswire/ -- - Strategic collaboration with Ipsen for marketing rights in Europe and the rest of the world except Nordics and the US - Photocure to commercialise the product directly in the US market Photocure ASA (OSE: PHO), a specialty pharmaceutical company focused on photodynamic technologies in dermatology and cancer, announces today the execution of a new commercial strategy for Hexvix, its...

SILVER SPRING, Md., Aug. 24, 2011 /PRNewswire-USNewswire/ -- The U.S. Food and Drug Administration today approved Botox (onabotulinumtoxinA) injection to treat urinary incontinence in people with neurologic conditions such as spinal cord injury and multiple sclerosis who have overactivity of the bladder. (Logo: http://photos.prnewswire.com/prnh/20090824/FDALOGO) Uninhibited urinary bladder contractions in people with some neurological conditions can lead to an inability to store urine....

(Ivanhoe Newswire) -- Nearly all patients with high-grade, non-invasive bladder cancer are not receiving the guideline-recommended care that would best protect them from recurrence, according to this study.In fact, out of the 4,545 bladder cancer patients included in the study, only one received the comprehensive care recommended by the American Urology Association and the National Comprehensive Cancer Network.Receiving the recommended comprehensive care for high-grade bladder cancer is...

A study at UCLA's Jonsson Comprehensive Cancer Center found that nearly all patients with high-grade, non-invasive bladder cancer are not receiving the guideline-recommended care that would best protect them from recurrence, a finding that researchers characterized as alarming.In fact, out of the 4,545 bladder cancer patients included in the study, only one received the comprehensive care recommended by the American Urology Association and the National Comprehensive Cancer Network.Receiving...

According to Dr. Joel Gelman, an internationally recognized expert in urethral stricture disease and Director of the Center for Reconstructive Urology at UC, Irvine Medical Center, urethral strictures can now be cured with up to a 98+% success rate with urethral reconstruction, including novel techniques recently reported at the 2010 American Urological Association Western Section Meeting. However, Dr. Gelman noted that men with urethral strictures continue to be advised to have their...

A number of resarch studies at Baylor College of Medicine are seeking participants. These studies are important because they help doctors and researchers uncover the disease process and find potential treatment and cures.A list of BCM research studies can be found at www.bcm.edu/clinicalstudies/. Among the studies listed:Older men with smoking history needed for bladder cancer screening studyMen over the age of 60 who have smoked for at least 20 years are being asked to participate in a...

SOMERVILLE, N.J., Aug. 10 /PRNewswire/ -- Ethicon, Inc., a worldwide leader in surgical care, has announced the availability of the GYNECARE TVT EXACT(TM) Continence System in the United States. GYNECARE TVT EXACT(TM) is a new minimally invasive surgical tool used in an outpatient setting for the treatment of stress urinary incontinence (SUI), a condition that affects one in three women in the U.S.(1). The product's integrated system offers an ergonomically designed handle to improve...

Bladder cancer "coaches," or people who have gone through treatment for the disease, may help current patients cope with their diagnosis and manage treatment, said a health researcher from Baylor College of Medicine."Because medical information can be complex, doctors may have difficulty relaying information about treatment procedures in a way that their patients understand," said Dr. David Latini, assistant professor in the Scott Department of Urology at BCM...

A new imaging agent used during standard imaging procedures may help physicians spot bladder cancer in its earlier stages, said a bladder oncologist from Baylor College of Medicine.This is significant because bladder cancer clinicians and researchers say early detection of bladder cancer is key to survival."The U.S. Food and Drug Administration recently approved (June 2010) a new imaging agent that can be used during a cystoscopy to help clinicians spot bladder cancer in an earlier...